Evidence map›Paper›PMID 24842903›Full record

ArticleMolecular and cellular biology2014

Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins.

Arjan J Groot, Roger Habets, Sanaz Yahyanejad, Caroline M Hodin, Karina Reiss, Paul Saftig, Jan Theys, Marc Vooijs

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapy.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Biological Significance of NOTCH Signaling Strength.Frontiers in cell and developmental biology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Arjan J GrootDepartment of Radiotherapy (MAASTRO)/GROW-School for Developmental Biology & Oncology, Maastricht University, Maastricht, Netherlands.
Roger HabetsDepartment of Radiotherapy (MAASTRO)/GROW-School for Developmental Biology & Oncology, Maastricht University, Maastricht, Netherlands.
Sanaz YahyanejadDepartment of Radiotherapy (MAASTRO)/GROW-School for Developmental Biology & Oncology, Maastricht University, Maastricht, Netherlands.
Caroline M HodinDepartment of Radiotherapy (MAASTRO)/GROW-School for Developmental Biology & Oncology, Maastricht University, Maastricht, Netherlands.
Karina ReissDepartment of Dermatology and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Paul SaftigInstitute of Biochemistry, University of Kiel, Kiel, Germany.
Jan TheysDepartment of Radiotherapy (MAASTRO)/GROW-School for Developmental Biology & Oncology, Maastricht University, Maastricht, Netherlands.
Marc VooijsDepartment of Radiotherapy (MAASTRO)/GROW-School for Developmental Biology & Oncology, Maastricht University, Maastricht, Netherlands marc.vooijs@maastrichtuniversity.nl.
Maastro Clinic · NLKiel University · DEMaastricht University · NLUniversity Hospital Schleswig-Holstein · DE

Funding

European Research Council 208259
6 · The paper itself

Abstract

In mammals, there are four NOTCH receptors and five Delta-Jagged-type ligands regulating many aspects of embryonic development and adult tissue homeostasis. NOTCH proteins are type I transmembrane receptors that interact with ligands on adjacent cells and are activated by regulated intramembrane proteolysis (RIP). The activation mechanism of NOTCH1 receptors upon ligand binding is well understood and requires cleavage by ADAM10 metalloproteases prior to intramembranous cleavage by γ-secretase. How the other human NOTCH receptor homologues are activated upon ligand binding is not known. Here, we dissect the proteolytic activation mechanism of the NOTCH2 and NOTCH3 receptors. We show that NOTCH2 and NOTCH3 signaling can be triggered by both Delta-Jagged-type ligands and requires ADAM10 and presenilin-1 or -2. Importantly, we did not find any role for the highly related ADAM17/TACE (tumor necrosis factor alpha-converting enzyme) protease in ligand-induced NOTCH2 or NOTCH3 signaling. These results demonstrate that canonical ligand-induced proteolysis of the NOTCH1, -2, and -3 receptors strictly depends on consecutive cleavage of these receptors by ADAM10 and the presenilin-containing γ-secretase complex, leading to transcriptional activation.

Indexed as

ADAM17 ProteinADAM ProteinsAmyloid Precursor Protein SecretasesAnimalsCell LineHEK293 CellsHumansMembrane ProteinsMetalloproteasesMiceNIH 3T3 CellsPresenilin-1Presenilin-2ProteolysisReceptor, Notch2Receptors, NotchADAM17 ProteinADAM17 protein, humanAdam17 protein, mouseADAM ProteinsAmyloid Precursor Protein SecretasesMembrane ProteinsMetalloproteasesPresenilin-1Presenilin-2Receptor, Notch2Receptors, Notch

Identifiers

PMID24842903
PMCPMC4135574
OpenAlexW2116173202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.